학술논문
SYK Inhibitors, Entospletinib and Lanraplenib, Show Potent Anti-Leukemic Activity in Combination with Targeted Agents
Document Type
Abstract
Author
Source
In Blood 15 November 2022 140 Supplement 1:5932-5933
Subject
Language
ISSN
0006-4971